ARCHIVES

BRAF Inhibitor Shrank Tumors In Phase II Genentech Study

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

As Zeneca Buys Salick, Implications For Oncology Managed Care Uncertain

April 4, 1997

ADT Does Not Raise Risk of Heart Attacks In Men With No History Of Heart Disease

November 25, 2011

Gene Vector Labs Seek Vector Producers

February 23, 1996

Funding Opportunity: PanCAN Offering $4.1 Million in Research Grants

September 12, 2014

CMS Withholds Coverage of CT Colonography

May 15, 2009

AACI Summarizes Position On New Core Guidelines

May 16, 1980